uniQure (QURE) Current Taxes (2024 - 2025)

uniQure's (QURE) quarterly Current Taxes came in at $7.8 million in Q3 2025, up 2569.28% quarter-over-quarter from $293000.0 in Q4 2024.

uniQure (QURE) Current Taxes (2024 - 2025) Analysis & Trends

uniQure's Current Taxes history runs 2 years deep, the most recent figure standing at $7.8 million for Q3 2025.

  • On a quarterly basis, Current Taxes changed N/A year-over-year to $7.8 million in Q3 2025; TTM through Sep 2025 was $7.8 million, a N/A change from a year earlier, with the FY2024 full-year figure at $293000.0, changed N/A from the prior year.
  • Current Taxes climbed to $7.8 million in Q3 2025 per QURE's latest filing, from $293000.0 in the prior quarter.
  • Across five years, Current Taxes topped out at $7.8 million in Q3 2025 and bottomed at $293000.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 63.52 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 49.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 uniQure 2.47 Bn 2.47 Bn 3.34 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 7.82 Mn
Dec 31, 2024 293,000.00